MSC-based product characterization for clinical trials: an FDA perspective
- PMID: 24506881
- DOI: 10.1016/j.stem.2014.01.013
MSC-based product characterization for clinical trials: an FDA perspective
Abstract
Proposals submitted to the FDA for MSC-based products are undergoing a rapid expansion that is characterized by increased variability in donor and tissue sources, manufacturing processes, proposed functional mechanisms, and characterization methods. Here we discuss the diversity in MSC-based clinical trial product proposals and highlight potential challenges for clinical translation.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
